Influence of food intake on bioavailability of theophylline in premature infants. 1982

G Heimann, and J Murgescu, and U Bergt

16 premature infants suffering from neonatal apnoea received orally an aqueous solution of theophylline 5 mg/kg bodyweight under fasting conditions and immediately before a milk feed. Bioavailability up to 7 h after administration was determined from the serum concentration-time course. The rate of absorption was significantly decreased if the drug was given with food; mean maximum serum concentrations were reached after 4.7 h instead of 1.6 h under fasting conditions. The area under the curve did not differ between the two patient groups which indicates that only the rate but not the amount of absorption was affected by food intake. The influence of feeding on the rate of absorption of theophylline by premature infants, which is more pronounced than in adults, can be related to particular functional factors in the gastrointestinal tract during the neonatal period.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D007235 Infant, Premature, Diseases Diseases that occur in PREMATURE INFANTS.
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001049 Apnea A transient absence of spontaneous respiration. Apneas
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

G Heimann, and J Murgescu, and U Bergt
July 1991, Arzneimittel-Forschung,
G Heimann, and J Murgescu, and U Bergt
January 1987, Drug-nutrient interactions,
G Heimann, and J Murgescu, and U Bergt
January 1976, Acta medica Scandinavica,
G Heimann, and J Murgescu, and U Bergt
April 1989, Journal of clinical pharmacy and therapeutics,
G Heimann, and J Murgescu, and U Bergt
January 1989, Pediatric hematology and oncology,
G Heimann, and J Murgescu, and U Bergt
October 1987, Clinical pharmacokinetics,
G Heimann, and J Murgescu, and U Bergt
January 1976, Journal of clinical pharmacology,
G Heimann, and J Murgescu, and U Bergt
May 1981, Clinical pharmacology and therapeutics,
G Heimann, and J Murgescu, and U Bergt
January 1996, European journal of clinical pharmacology,
G Heimann, and J Murgescu, and U Bergt
June 1989, International journal of clinical pharmacology, therapy, and toxicology,
Copied contents to your clipboard!